Forty Seven (FTSV) Short Interest Ratio & Short Volume

Short interest is the volume of Forty Seven shares that have been sold short but have not yet been covered or closed out. As of March 13th, traders have sold 940,300 shares of FTSV short. 3.02% of Forty Seven's shares are currently sold short. Learn More on Forty Seven's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.02% of Forty Seven's floating shares are currently sold short.

Forty Seven saw a drop in short interest in the month of March. As of March 13th, there was short interest totaling 940,300 shares, a drop of 54.6% from the previous total of 2,070,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Forty Seven currently has issued a total of 48,156,000 shares. Some of Forty Seven's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Forty Seven currently has a public float of 31,140,000 shares.

3.02% of Forty Seven's shares are currently sold short. Here is how the short interest of companies compare to Forty Seven: Intra-Cellular Therapies, Inc. (2.58%), Zymeworks Inc. (10.61%), Chimerix, Inc. (4.27%), Avid Bioservices, Inc. (18.17%), Revance Therapeutics, Inc. (4.32%), Checkpoint Therapeutics, Inc. (6.19%), Aerovate Therapeutics, Inc. (21.72%), 2seventy bio, Inc. (5.37%), Acelyrin, Inc. (4.87%), Procaps Group S.A. (0.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AbbVie Inc. ($6.51 billion), Charter Communications, Inc. ($4.96 billion), McKesson Corporation ($4.86 billion), Microchip Technology Incorporated ($2.85 billion), The Charles Schwab Corporation ($2.75 billion), Match Group Inc. ($2.50 billion), International Flavors & Fragrances Inc. ($1.95 billion), Tiffany & Co. ($1.93 billion), Wayfair Inc. ($1.78 billion), and Hormel Foods Corporation ($1.77 billion). View all of the most shorted stocks.

Short selling FTSV is an investing strategy that aims to generate trading profit from Forty Seven as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Forty Seven occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FTSV, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FTSV, twice per month. The most recent reporting period available is March, 13 2020.